Artwork

Content provided by BBC and BBC Radio 4. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BBC and BBC Radio 4 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Clot risks: The Pill versus the vaccine

8:58
 
Share
 

Manage episode 289615375 series 1301260
Content provided by BBC and BBC Radio 4. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BBC and BBC Radio 4 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Astra Zeneca Covid 19 jab remains in the headlines because some regulators have concluded that it may raise the risk of a very rare type of blood clot, albeit to a risk that is still very low. In the past few weeks a number of countries have said they will limit its use to older age groups. But people are drawing comparisons to the contraceptive pill which is well-known to increase the risk of clots and asking why this level of risk is tolerated. Is this comparison fair? Tim Harford speaks to Professor Frits Rosendaal from the University of Leiden in the Netherlands and Susan Ellenberg, professor of biostatistics at the University of Pennsylvania.

  continue reading

976 episodes

Artwork
iconShare
 
Manage episode 289615375 series 1301260
Content provided by BBC and BBC Radio 4. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by BBC and BBC Radio 4 or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

The Astra Zeneca Covid 19 jab remains in the headlines because some regulators have concluded that it may raise the risk of a very rare type of blood clot, albeit to a risk that is still very low. In the past few weeks a number of countries have said they will limit its use to older age groups. But people are drawing comparisons to the contraceptive pill which is well-known to increase the risk of clots and asking why this level of risk is tolerated. Is this comparison fair? Tim Harford speaks to Professor Frits Rosendaal from the University of Leiden in the Netherlands and Susan Ellenberg, professor of biostatistics at the University of Pennsylvania.

  continue reading

976 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide